BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34324740)

  • 41. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
    Peng H; Pan X; Su Q; Zhu LS; Ma GD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.
    Lacerda JZ; Ferreira LC; Lopes BC; Aristizábal-Pachón AF; Bajgelman MC; Borin TF; Zuccari DAPC
    Microrna; 2019; 8(3):237-247. PubMed ID: 30806335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
    Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
    World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of DKK3 by miR-483-3p plays an important role in the chemoprevention of colorectal cancer mediated by black raspberry anthocyanins.
    Guo J; Yang Z; Zhou H; Yue J; Mu T; Zhang Q; Bi X
    Mol Carcinog; 2020 Feb; 59(2):168-178. PubMed ID: 31763724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
    Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
    J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
    Han MS; Lee JM; Kim SN; Kim JH; Kim HS
    Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-95-3p inhibits cell proliferation and metastasis in colorectal carcinoma by HDGF.
    Hong YG; Huang ZP; Liu QZ; E JF; Gao XH; Xin C; Zhang W; Li P; Hao LQ
    Biomed J; 2020 Apr; 43(2):163-173. PubMed ID: 32418767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2.
    Liu D; Chen C; Cui M; Zhang H
    Cancer Med; 2021 May; 10(10):3358-3372. PubMed ID: 33838016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-149-3p reverses CD8
    Zhang M; Gao D; Shi Y; Wang Y; Joshi R; Yu Q; Liu D; Alotaibi F; Zhang Y; Wang H; Li Q; Zhang ZX; Koropatnick J; Min W
    Open Biol; 2019 Oct; 9(10):190061. PubMed ID: 31594465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer.
    Qu LL; He L; Zhao X; Xu W
    Int J Mol Med; 2015 May; 35(5):1266-72. PubMed ID: 25812680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
    Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X
    J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonistic activities of miR-148a and DNMT1: Ectopic expression of miR-148a impairs DNMT1 mRNA and dwindle cell proliferation and survival.
    Sengupta D; Deb M; Patra SK
    Gene; 2018 Jun; 660():68-79. PubMed ID: 29596883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
    Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
    J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA-SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR-338-3p.
    Li M; Bian Z; Jin G; Zhang J; Yao S; Feng Y; Wang X; Yin Y; Fei B; You Q; Huang Z
    Cancer Med; 2019 May; 8(5):2404-2413. PubMed ID: 30945457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR-148a-3p/ROCK1 axes.
    Pan L; Meng Q; Li H; Liang K; Li B
    Biomed Pharmacother; 2019 Dec; 120():109423. PubMed ID: 31550677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
    Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
    Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma.
    Wang Q; Huang Z; Guo W; Ni S; Xiao X; Wang L; Huang D; Tan C; Xu Q; Zha R; Zhang J; Sheng W; He X; Du X
    Clin Cancer Res; 2014 Mar; 20(5):1146-57. PubMed ID: 24327274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.